For PSA glycans, higher levels of α2,3-linked sialylation are found in patients with high-risk prostate cancer [42], while for AFP glycosylation, the level of core fucosylation is positively associated with the occurrence of hepatocellular carcinoma and its progression [43]. The gene discussed is KLK3; the disease is prostate cancer.